Boswellia
Specifically for Asthma
0 up • 0 down
Why it works for Asthma:
Targets leukotrienes (inflammation pathway central to asthma). A key boswellia constituent—AKBA (3-acetyl-11-keto-β-boswellic acid)—directly inhibits the 5-lipoxygenase (5-LOX) enzyme that drives leukotriene production. Leukotrienes contribute to bronchoconstriction, mucus, and airway inflammation in asthma. Mechanistic work shows AKBA is a direct, non-redox 5-LOX inhibitor with a distinct binding site on the enzyme. ScienceDirect
Additional anti-inflammatory actions (e.g., effects on leukocyte elastase and other inflammatory mediators) have been described, which could also reduce airway inflammation. jpet.aspetjournals.org
The mechanism (leukotriene reduction) is directly relevant to asthma biology, similar in pathway to prescription leukotriene-modifier drugs—even though Boswellia itself is not a medicine and products aren’t standardized like drugs.
How to use for Asthma:
Form & standardization: Use an oral extract of Boswellia serrata (capsules/tablets). Many commercial extracts are standardized to boswellic acids (commonly ~30–40%); some specialty extracts are enriched for AKBA (e.g., 5-Loxin/Aflapin) but these haven’t been tested for asthma outcomes. Examine
Dose used in the asthma RCT: 300 mg, three times daily of Boswellia gum resin for 6 weeks (total 900 mg/day). This is the clearest, asthma-specific regimen in the literature. Europe PMC
General supplement references (non-asthma-specific): Many list ~300–500 mg of standardized extract 2–3×/day, taken with food to reduce GI upset. These are general ranges, not asthma-validated dosing. RxList
How to integrate with asthma care (important):
- Do not stop inhaled corticosteroid (ICS)–containing therapy or reliever inhalers without your prescriber’s advice. Current asthma guidelines prioritize ICS-containing inhalers for everyone with asthma. Global Initiative for Asthma - GINA
- If you and your clinician decide to try Boswellia, consider a time-limited trial (e.g., 6 weeks) alongside guideline-based therapy, tracking symptoms/peak flows and side effects.
Scientific Evidence for Asthma:
Double-blind, placebo-controlled RCT (40 adults with chronic bronchial asthma, 6 weeks): Boswellia gum resin 300 mg TID vs placebo. Reported improvements in symptoms (dyspnea, wheeze, attack frequency) and spirometry in the Boswellia group (about 70% responders vs 27% on placebo). (European Journal of Medical Research, 1998; PMID 9810030). Note: small, short, older study; product standardization details are limited. Europe PMC
Mechanism papers: Multiple in-vitro/biophysical studies show AKBA inhibits 5-LOX (the leukotriene-producing enzyme), supporting biological plausibility. ScienceDirect
Reviews of frankincense/boswellia trials across conditions: A BMJ systematic review (2008) judged overall RCT evidence across indications as limited and heterogeneous (most trials small/short), underscoring the need for better studies; it does not establish asthma efficacy. BMJ
Authoritative consumer-health summary: NCCIH (NIH) concludes only a few small studies suggest Boswellia may reduce asthma symptoms and that evidence is not rigorous enough to determine usefulness. NCCIH
Specific Warnings for Asthma:
Do not substitute for prescription therapy. If you have asthma, follow your clinician’s plan; discuss any supplement before starting (risk of interactions; uncontrolled asthma can be dangerous). NCCIH
Side effects: Generally mild—GI upset (nausea, diarrhea), heartburn, and skin rash are most often reported. RxList
Pregnancy & breastfeeding: Human safety data are insufficient; authoritative sources advise avoiding medicinal doses in pregnancy/breastfeeding unless specifically recommended by a clinician. NCCIH
Drug interactions (theoretical/possible):
- Anticoagulants/antiplatelets (e.g., warfarin): Some references flag possible interaction risk; consult your prescriber and monitor if on such drugs. Evidence is limited and inconsistent, but caution is warranted. RxList
- General CYP interactions: In-vitro data suggest potential effects on drug-metabolizing enzymes; clinical relevance unclear—again, flag to your clinician/pharmacist. Hello Pharmacist
Quality & standardization: Supplements are not regulated like medicines; pick brands with third-party testing (USP/NSF/ISO) and consistent boswellic-acid content. NCCIH
Allergies: Avoid if you’ve had reactions to frankincense/Boswellia resins. (General safety caveat.) RxList
General Information (All Ailments)
What It Is
Boswellia, also known as Indian frankincense, is a resin extracted from the bark of trees in the Boswellia genus — particularly Boswellia serrata. The resin has been used for centuries in traditional Ayurvedic and Chinese medicine to treat various inflammatory conditions.
The active compounds in Boswellia are boswellic acids, including acetyl-11-keto-β-boswellic acid (AKBA), which is believed to be primarily responsible for its therapeutic effects.
Boswellia is commonly available in:
- Resin form (for burning or topical use)
- Capsules or tablets (standardized extracts)
- Creams and ointments (for joint pain)
- Essential oils (for aromatherapy or topical applications)
How It Works
Boswellia works mainly by modulating the body’s inflammatory response through several biochemical pathways:
- Inhibition of 5-Lipoxygenase (5-LOX):
- Boswellic acids block the enzyme 5-LOX, which is involved in the production of leukotrienes — inflammatory molecules that play a role in asthma, arthritis, and inflammatory bowel diseases.
- Reduction of Pro-inflammatory Cytokines:
- It helps reduce levels of inflammatory mediators like tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6).
- Prevention of Cartilage Breakdown:
- Boswellia may help protect joint cartilage by inhibiting enzymes (such as MMPs) that degrade connective tissue, making it useful for osteoarthritis.
- Antioxidant and Immunomodulatory Effects:
- Boswellia also exerts antioxidant actions that help reduce oxidative stress and may improve overall immune function.
Why It’s Important
Boswellia has attracted modern scientific interest because it provides natural anti-inflammatory effects comparable to some nonsteroidal anti-inflammatory drugs (NSAIDs), but with fewer gastrointestinal side effects.
Key potential benefits include:
- Joint Health: May improve flexibility and reduce pain and swelling in osteoarthritis and rheumatoid arthritis.
- Respiratory Support: Helps manage asthma and bronchial inflammation.
- Digestive Health: May reduce symptoms of inflammatory bowel diseases (Crohn’s disease, ulcerative colitis).
- Brain and Cognitive Function: Early research suggests potential neuroprotective effects, possibly beneficial in neuroinflammatory conditions.
- Overall Well-being: Because chronic inflammation is linked to many diseases, Boswellia’s modulation of inflammatory pathways supports systemic health.
Considerations
While Boswellia is generally well tolerated, there are important factors to consider:
1. Safety and Side Effects
- Common side effects are mild and may include nausea, diarrhea, acid reflux, or skin rashes.
- Rarely, allergic reactions may occur.
- Long-term high-dose use has not been extensively studied.
2. Interactions
- May interact with anti-inflammatory or anticoagulant medications (e.g., NSAIDs, warfarin).
- Should be used cautiously with other herbs or supplements affecting inflammation or the immune system.
3. Dosage and Standardization
- Typical doses of Boswellia serrata extract range from 300–500 mg, taken 2–3 times daily, standardized to contain 30–65% boswellic acids.
- Consistency in formulation is crucial, as potency can vary widely among products.
4. Pregnancy and Medical Conditions
- Not enough research exists to confirm safety during pregnancy or breastfeeding.
- People with gastrointestinal conditions or taking medications should consult a healthcare professional before use.
5. Quality and Purity
- Look for standardized extracts (e.g., 65% boswellic acids or specific AKBA content).
- Choose products tested for contaminants (heavy metals, adulteration).
Helps with these conditions
Boswellia is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Crohn's Disease
Boswellia's therapeutic potential in Crohn’s disease is primarily attributed to its active compounds, particularly boswellic acids, which are believed...
Arthritis
The active molecules in Boswellia (boswellic acids — especially 3-O-acetyl-11-keto-β-boswellic acid, AKA AKBA) inhibit 5-lipoxygenase (5-LOX), an enzy...
Back Pain
Boswellia’s main actives (boswellic acids—especially AKBA) inhibit 5-lipoxygenase (5-LOX) and reduce leukotriene production, key mediators of inflamma...
Asthma
Targets leukotrienes (inflammation pathway central to asthma). A key boswellia constituent—AKBA (3-acetyl-11-keto-β-boswellic acid)—directly inhibits...
Diverticulitis
Anti-inflammatory mechanism: The most active Boswellia constituents (boswellic acids — especially 3-O-acetyl-11-keto-β-boswellic acid, AKBA) inhibit 5...
Sciatica
Sciatica pain is most often driven by inflammation around a compressed or irritated lumbar nerve root. Boswellia’s major acids—especially AKBA (acetyl...
Psoriasis
Lowers leukotrienes (5-LOX inhibition): Boswellic acids—especially AKBA—directly inhibit 5-lipoxygenase, reducing leukotriene-driven inflammation impl...
Rheumatoid Arthritis
Anti-inflammatory pathways: Boswellic acids—especially AKBA (3-O-acetyl-11-keto-β-boswellic acid)—inhibit 5-lipoxygenase (5-LOX), lowering leukotriene...
Tendonitis
Boswellia has plausible anti-inflammatory mechanisms and decent human data for joint pain (especially osteoarthritis). Direct, high-quality trials for...
Carpal Tunnel Syndrome
Anti-inflammatory mechanism: Boswellic acids—especially AKBA (acetyl-11-keto-β-boswellic acid)—are direct, non-redox inhibitors of 5-lipoxygenase (5-L...
Multiple Sclerosis
Leukotriene pathway / 5-lipoxygenase (5-LOX) inhibition. The main boswellic acid, AKBA, is an allosteric inhibitor of 5-LOX, a key enzyme in leukotrie...
Temporomandibular Joint Disorder
It targets the leukotriene pathway (5-LOX). The most active boswellic acid (AKBA) directly inhibits 5-lipoxygenase, lowering leukotrienes that drive i...
Rheumatoid Osteoarthritis
Leukotriene pathway inhibition (5-LOX): AKBA (3-acetyl-11-keto-β-boswellic acid), a key boswellic acid, directly inhibits 5-lipoxygenase, lowering pro...
Pleurisy
Boswellia (Indian frankincense, Boswellia serrata) has well-documented anti-inflammatory actions (notably via boswellic acids such as AKBA inhibiting...
Community Discussion
Share results, tips, and questions about Boswellia.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Asthma
Talk specifically about using Boswellia for Asthma.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.